Alopecia Areata
193
27
40
82
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
44 trials with published results (23%)
Research Maturity
82 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
8.8%
17 terminated out of 193 trials
82.8%
-3.7% vs benchmark
22%
42 trials in Phase 3/4
54%
44 of 82 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 82 completed trials
Clinical Trials (193)
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata
Intralesional Cyclosporine for Alopecia Areata
An Observational Study of Patients With Dermatologic Disease
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata
Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata
The Role of Gut and Skin Microbiota in Alopecia Areata
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
New Topical Treatment in Patchy Alopecia Areata
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
Regeneron AA Multicenter (Dupilumab)
Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata